Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components

[Image: see text] Gene editing mediated by CRISPR/Cas9 systems is due to become a beneficial therapeutic option for treating genetic diseases and some cancers. However, there are challenges in delivering CRISPR components which necessitate sophisticated delivery systems for safe and effective genome...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazemian, Pardis, Yu, Si-Yue, Thomson, Sarah B., Birkenshaw, Alexandra, Leavitt, Blair R., Ross, Colin J. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176214/
https://www.ncbi.nlm.nih.gov/pubmed/35594500
http://dx.doi.org/10.1021/acs.molpharmaceut.1c00916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176214/
https://www.ncbi.nlm.nih.gov/pubmed/35594500
http://dx.doi.org/10.1021/acs.molpharmaceut.1c00916

Ejemplares similares